Unigene names president, CEO

Unigene Laboratories has appointed Ashleigh Palmer as president and CEO of the company, replacing Warren Levy. Release

Immunovaccine has tapped Keith Abriel as acting CFO. Abriel will fulfill the role until a permanent appointment is made. Release

Ikaria has announced that Geoffrey Nichol has been appointed chief medical officer. Nichol will be responsible for activities related to late-stage drug development. Release

Laurent Audoly has joined Pieris as chief scientific officer, effective immediately. Release

Biocodex USA has announced that Rajesh Gupta has joined the company in the newly-created position of director of medical & scientific affairs. Release

Gilead Sciences has announced that John McHutchison will join the company as senior VP, Liver Disease Therapeutics. Release

Genzyme's nominating and corporate governance committee of its board of directors has nominated Dennis Fenton for election to the board. He was executive VP of operations at Amgen when he retired from the company in 2008. Release

Jazz Pharmaceuticals has appointed Paul Berns to the company's board of directors. Release

StemCells has named R. Scott Greer to its board of directors. Release

Rexahn Pharmaceuticals has hired Frederick Frank, the current vice-chairman of Peter J. Solomon Co (PJSC), to advise on a range of corporate activities. Release

Oragenics has announced that Frederick Telling and Charles Pope have formally joined the company's board of directors. Release

Dr. Inder Kaul has joined Asiatic Clinical Research as an independent director. Release

Suggested Articles

Preclinical-stage biotech Abpro Therapeutics wants to trial its two lead candidates for HER2-positive cancers and diabetic macular edema in 2019.

After a rough patch in 2017, the stars seem to be realigning for French CAR-T expert Cellectis, which just closed a $164 million U.S. public offering.

Investment firm Frazier Healthcare Partners has closed its 11th fund—worth $780 million—that will help established companies accelerate their growth.